MX2015011783A - Metodos para tratar tumores solidos pediatricos. - Google Patents

Metodos para tratar tumores solidos pediatricos.

Info

Publication number
MX2015011783A
MX2015011783A MX2015011783A MX2015011783A MX2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A
Authority
MX
Mexico
Prior art keywords
solid tumor
methods
treatment
pediatric solid
pediatric
Prior art date
Application number
MX2015011783A
Other languages
English (en)
Inventor
Neil P Desai
Markus Renschler
Bouchra Benettaib
Ileana Elias
Original Assignee
Abraxis Bioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abraxis Bioscience Llc filed Critical Abraxis Bioscience Llc
Publication of MX2015011783A publication Critical patent/MX2015011783A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)

Abstract

La presente invención proporciona métodos y composiciones para el tratamiento de tumores sólidos pediátricos mediante la administración de una composición que comprende nanopartículas que comprenden un taxano y una albúmina.
MX2015011783A 2013-03-13 2014-03-10 Metodos para tratar tumores solidos pediatricos. MX2015011783A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361780658P 2013-03-13 2013-03-13
US201361805817P 2013-03-27 2013-03-27
US201361829940P 2013-05-31 2013-05-31
US201361909868P 2013-11-27 2013-11-27
PCT/US2014/022541 WO2014143613A1 (en) 2013-03-13 2014-03-10 Methods of treatment of pediatric solid tumor

Publications (1)

Publication Number Publication Date
MX2015011783A true MX2015011783A (es) 2015-12-01

Family

ID=51537501

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011783A MX2015011783A (es) 2013-03-13 2014-03-10 Metodos para tratar tumores solidos pediatricos.

Country Status (12)

Country Link
US (1) US20160015817A1 (es)
EP (1) EP2968253A4 (es)
JP (3) JP6387389B2 (es)
KR (1) KR20150126671A (es)
CN (1) CN105209035A (es)
AU (2) AU2014228386B2 (es)
CA (1) CA2903470A1 (es)
HK (1) HK1219231A1 (es)
IL (1) IL240987A0 (es)
MX (1) MX2015011783A (es)
NZ (1) NZ630367A (es)
WO (1) WO2014143613A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
SI2117520T1 (sl) 2006-12-14 2019-01-31 Abraxis Bioscience, Llc Zdravljenje raka dojk glede na status hormonskih receptorjev z nano delci, ki zajemajo taksan
DK2419732T3 (da) 2009-04-15 2019-12-16 Abraxis Bioscience Llc Prionfrie nanopartikelsammensætninger og fremgangsmåder
RU2016119999A (ru) 2010-03-29 2018-11-08 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Способы лечения онкологических заболеваний
NZ602635A (en) 2010-03-29 2014-12-24 Abraxis Bioscience Llc Methods of enhancing drug delivery and effectiveness of therapeutic agents
US9399071B2 (en) 2010-06-04 2016-07-26 Abraxis Bioscience, Llc Methods of treatment of pancreatic cancer
BR112013027674A2 (pt) 2011-04-28 2016-09-06 Abraxis Bioscience Llc "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
PL2790675T3 (pl) 2011-12-14 2019-12-31 Abraxis Bioscience, Llc Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
US9149455B2 (en) 2012-11-09 2015-10-06 Abraxis Bioscience, Llc Methods of treating melanoma
US9511046B2 (en) 2013-01-11 2016-12-06 Abraxis Bioscience, Llc Methods of treating pancreatic cancer
CN105228612A (zh) 2013-03-12 2016-01-06 阿布拉科斯生物科学有限公司 治疗肺癌的方法
ES2881851T3 (es) 2013-03-14 2021-11-30 Abraxis Bioscience Llc Métodos para tratar el cáncer de vejiga
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
PL3313401T3 (pl) 2015-06-29 2022-02-07 Abraxis Bioscience, Llc Nanocząsteczki zawierające sirolimus i albuminę do stosowania w leczeniu nowotworów z komórek epitelioidnych
CN112188892A (zh) 2018-03-20 2021-01-05 阿布拉科斯生物科学有限公司 通过mTOR抑制剂和白蛋白的纳米颗粒的施用治疗中枢神经系统障碍的方法
MX2022004989A (es) 2019-10-28 2022-07-21 Abraxis Bioscience Llc Composiciones farmaceuticas de albumina y rapamicina.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6096331A (en) 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
CN1101700C (zh) * 1997-12-05 2003-02-19 上海众联生化技术开发有限公司 多肽口服液
ITMI20001107A1 (it) * 2000-05-18 2001-11-18 Acs Dobfar Spa Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
TR200502189T1 (tr) 2002-12-09 2007-01-22 American Bioscience, Inc. Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
CN1261161C (zh) * 2003-11-10 2006-06-28 钱汶光 复方干扰素诱生剂口含片
HUE038768T2 (hu) 2005-02-18 2018-11-28 Abraxis Bioscience Llc Terápiás szerek kombinációi, valamint beadásukra szolgáló módszerek, és kombinációs terápia
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
WO2008137148A2 (en) 2007-05-03 2008-11-13 Abraxis Bioscience, Llc Methods and compositions for treating pulmonary hypertension
EP2502078A1 (en) * 2009-11-20 2012-09-26 Infinity Pharmaceuticals, Inc. Methods and compositions for treating hedgehog-associated cancers
NZ602635A (en) * 2010-03-29 2014-12-24 Abraxis Bioscience Llc Methods of enhancing drug delivery and effectiveness of therapeutic agents
NZ708506A (en) * 2010-06-02 2016-08-26 Abraxis Bioscience Llc Methods of treating bladder cancer

Also Published As

Publication number Publication date
NZ630367A (en) 2017-02-24
EP2968253A4 (en) 2016-11-02
CA2903470A1 (en) 2014-09-18
CN105209035A (zh) 2015-12-30
JP2016512513A (ja) 2016-04-28
AU2014228386A1 (en) 2015-09-24
AU2019201357A1 (en) 2019-03-21
JP2019163334A (ja) 2019-09-26
JP2018062528A (ja) 2018-04-19
AU2014228386B2 (en) 2018-11-29
JP6387389B2 (ja) 2018-09-05
EP2968253A1 (en) 2016-01-20
WO2014143613A1 (en) 2014-09-18
HK1219231A1 (zh) 2017-03-31
US20160015817A1 (en) 2016-01-21
KR20150126671A (ko) 2015-11-12
IL240987A0 (en) 2015-11-30

Similar Documents

Publication Publication Date Title
MX2015011783A (es) Metodos para tratar tumores solidos pediatricos.
PH12016502066A1 (en) Methods of treating bladder cancer
MX2015011753A (es) Metodos para tratar cancer de vegija.
MX2015010312A (es) Metodos para tratamiento del melanoma.
HK1213925A1 (zh) 用於治療癌症的涉及抗密蛋白 抗體的組合療法
MX2021002455A (es) Metodos para tratar tumores de celulas epitelioides.
IL273090B (en) Methods and preparations for the treatment of cancer
MX2015008889A (es) Metodo para tratar cancer con base en el estado de la mutacion k-ras.
MX2016007885A (es) Metodos de tratamiento de cancer usando antagonistas de union del eje de pd-1 y un anticuerpo anti-cd20.
EA201992251A1 (ru) Противораковые вакцины и способы лечения с их применением
MX2020009223A (es) Anticuerpos anti-fgfr2iiib afucosilados.
PH12015502161A1 (en) Therapeutic compounds and compositions
NZ719049A (en) Cancer treatment with combination of plinabulin and taxane
MX2015010829A (es) Compuestos terapeuticos y sus usos.
EA201591925A1 (ru) Терапевтические композиции и их применение
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
RS63738B1 (sr) Kombinovana terapija koja uključuje antitela protiv klaudina 18.2 za lečenje kancera
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
EA201690445A1 (ru) Лечение рака
NZ725354A (en) Transdermal formulations of pergolide and uses thereof
BR112016005917A2 (pt) conjugados de partículas semelhantes a vírus para diagnóstico e tratamento de tumores